BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,104,294 | -52.1% | 461,717 | -36.4% | 0.00% | -60.0% |
Q2 2023 | $23,181,979 | +15.0% | 726,025 | +10.3% | 0.01% | +25.0% |
Q1 2023 | $20,155,860 | -49.4% | 658,258 | -35.4% | 0.00% | -55.6% |
Q4 2022 | $39,829,311 | -20.5% | 1,018,392 | -3.2% | 0.01% | -25.0% |
Q3 2022 | $50,102,000 | +35.7% | 1,051,676 | +10.2% | 0.01% | +50.0% |
Q2 2022 | $36,927,000 | -22.3% | 953,927 | +15.0% | 0.01% | -20.0% |
Q1 2022 | $47,516,000 | -38.8% | 829,247 | -14.9% | 0.01% | -33.3% |
Q4 2021 | $77,619,000 | -14.6% | 974,018 | -6.7% | 0.02% | -21.1% |
Q3 2021 | $90,846,000 | +8.9% | 1,044,082 | +61.1% | 0.02% | 0.0% |
Q2 2021 | $83,410,000 | +41.9% | 648,044 | -11.7% | 0.02% | +26.7% |
Q1 2021 | $58,766,000 | -14.4% | 734,217 | -12.7% | 0.02% | -16.7% |
Q4 2020 | $68,675,000 | +796.1% | 841,193 | +170.2% | 0.02% | +800.0% |
Q3 2020 | $7,664,000 | -13.0% | 311,289 | -1.0% | 0.00% | -33.3% |
Q2 2020 | $8,807,000 | +34.8% | 314,537 | -13.3% | 0.00% | +50.0% |
Q1 2020 | $6,534,000 | – | 362,958 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |